Triple hybrids of steroids, spiroketals, and oligopeptides as new biomolecular chimeras

Organic Letters

Volumn 11, Issue 1, 2009, Pages 65-68

  Banerjee, Abhisek ^a   Sergienko, Eduard ^b   Vasile, Stefan ^b   Gupta, Vineet ^c   Vuori, Kristiina ^b   Wipf, Peter ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; OLIGOPEPTIDE; SPIRO COMPOUND; STEROID;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

ANTIGENS, CD11B; ANTIGENS, CD18; MOLECULAR STRUCTURE; OLIGOPEPTIDES; OXIDATION-REDUCTION; SPIRO COMPOUNDS; STEREOISOMERISM; STEROIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 59649094100     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol802247m     Document Type: Article

References (47)

1. Salunke, D. B.; Hazra, B. G.; Pore, V. S. Curr. Med. Chem. 2006, 13, 813-847.
2. (a) Mbadugha, B. N. A.; Menger, F. M. Org. Lett. 2003, 5, 4041-4044.
3. (b) Cheng, Y.; Ho, D. M.; Gottlieb, C. R.; Kahne, D.; Brack, M. A. J. Am. Chem. Soc. 1992, 114, 7319-7320.
4. (a) Madder, A.; Li, L.; De Muynck, H.; Farcy, N.; Van Haver, D.; Fant, F.; Vanhoenacker, G.; Sandra, P.; Davis, A. P.; De Clercq, P. J. J. Comb. Chem. 2002, 4, 552-562.
5. (b) De Muynck, H.; Madder, A.; Farcy, N.; De Clercq, P. J.; Perez-Payan, M. N.; Ohberg, L. M.; Davis, A. P. Angew. Chem., Int. Ed. 2000, 39, 145-148.
6. (a) Bhattarai, K. M.; Del Amo, V.; Magro, G.; Sisson, A. L.; Joos, J.-B.; Charmant, J. P. H.; Kantacha, A.; Davis, A. P. Chem. Commun. 2006, 2335-2337.
7. (b) Ding, B.; Taotofa, U.; Orsak, T.; Chadwell, M.; Savage, P. B. Org. Lett. 2004, 6, 3433-3436.
8. (a) Cheng, Y.; Suenaga, T.; Still, W. C. J. Am. Chem. Soc. 1996, 118, 1813-1814.
9. (b) Boyce, R.; Li, G.; Nestler, H. P.; Suenaga, T.; Still, W. C. J. Am. Chem. Soc. 1994, 116, 7955-7956.
10. (a) Tanaka, J.; Trianto, A.; Musman, M.; Issa, H. H.; Ohtani, I. I.; Ichiba, T.; Higa, T.; Yoshida, W. Y.; Scheuer, P. J. Tetrahedron 2002, 58, 6259-6266. See also:
11. (b) Anjaneyulu, A. S. R.; Rao, V. L.; Sastry, V. G. Nat. Prod. Res. 2003, 17, 149-152.
12. Lee, S.; Lacour, T. G.; Lantrip, D.; Fuchs, P. L. Org. Lett. 2002, 4, 313-316.
13. Rivera, D. G.; Pando, O.; Coll, F. Tetrahedron 2006, 62, 8327-8334.
14. Wessjohann, L. A.; Voigt, B.; Rivera, D. G. Angew. Chem., Int. Ed. 2005, 44, 4785-4790.
15. Waller, D. L.; Stephenson, C. R. J.; Wipf, P. Org. Biomol. Chem. 2007, 5, 58-60.
16. Ruoslahti, E.; Pierschbacher, M. D. Science 1987, 238, 491-497.
17. (a) Andronati, S. A.; Karaseva, T. L.; Krysko, A. A. Curr. Med. Chem. 2004, 11, 1183-1211.
18. (b) Cacciari, B.; Spalluto, G. Curr. Med. Chem. 2005, 12, 51-70.
19. (c) Carlson, C. B.; Mowery, P.; Owen, R. M.; Dykhuizen, E. C.; Kiessling, L. L. ACS Chem. Biol. 2007, 2, 119-127.
20. Gentilucci, L.; Cardillo, G.; Squassabia, F.; Tolomelli, A.; Spampinato, S.; Sparta, A.; Baiula, M. Bioorg. Med. Chem. Lett. 2007, 17, 2329-2333.
21. Paquette, L. A.; Andrews, J. F. P.; Vanucci, C.; Lawhorn, D. E.; Negri, J. T.; Rogers, R. D. J. Ors. Chem. 1992, 57, 3956-3965.
22. 4 (1:1) gave no improvement in yield.
23. Palasek, S. A.; Cox, Z. J.; Collins, J. M. J. Pept. Sci. 2007, 13, 143-148.
24. Hoegberg, T.; Stroem, P.; Ebner, M.; Raemsby, S. J. Org. Chem. 1987, 52, 2033-2036.
25. Solladie-Cavallo, A.; Bencheqroun, M. J. Org. Chem. 1992, 57, 5831-5834.
26. (a) Lipton, M. F.; Basha, A.; Weinreb, S. M. Org. Synth. 1980, 59, 49-53.
27. (b) Ley, S. V.; Mynett, D. M.; Koot, W.-J. Synlett 1995, 1017-1020.
28. The acid-labile FMPB-AM resin (Novabiochem) uses a PS bead attached to a BAL-type linker, 4-(4-formyl-3-methoxyphenoxy) butyrylamide. Other resins, including standard Rink-amide, failed.
29. (a) Alsina, J.; Jensen, K. J.; Albericio, F.; Barany, G. Chem. Eur. J. 1999, 5, 2787-2795.
30. (b) Boojamra, C. G.; Burow, K. M.; Thompson, L. A.; Ellman, J. A. J. Org. Chem. 1997, 62, 1240-1256.
31. (c) Yoshida, M.; Hayakawa, I.; Hayashi, N.; Agatsuma, T.; Oda, Y.; Tanzawa, F.; Iwasaki, S.; Koyama, K.; Furukawa, H.; Kurakata, S.; Sugano, Y. Bioorg. Med. Chem. Lett. 2005, 15, 3328-3332.
32. (d) Boeglin, D.; Bonnet, D.; Hibert, M. J. Comb. Chem. 2007, 9, 487-500.
33. A CEM monomode microwave peptide synthesizer was used, with individual coupling times of 3-8 min per residue. For other recent applications of microwave radiation to accelerate SPPS, see: (a) Murray, J. K.; Gellman, S. H. Nat. Protoc. 2007, 2, 624-631.
34. (b) Bacsa, B.; Kappe, C. O. Nat. Protoc. 2007, 2, 2222-2227.
35. (c) Gorske, B. C.; Jewell, S. A.; Guerard, E. J.; Blackwell, H. E. Org. Lett. 2005, 7, 1521-1524.
36. See, for example Gentilucci, L.; Cardillo, G.; Squassabia, F.; Tolomelli, A.; Spampinato, S.; Sparta, A.; Baiula, M. Bioorg. Med. Chem. Lett. 2007, 17, 2329-2333.
37. The assay was an adaptation of Park, J. Y.; Arnaout, M. A.; Gupta, V. J. Biomol Screen. 2007, 12, 406-417.
38. (a) Wipf, P.; Stephenson, C. R. J. Org. Lett. 2005, 7, 1137-1140.
39. (b) Wipf, P.; Werner, S.; Woo, G. H. C.; Stephenson, C. R. J.; Walczak, M. A. A.; Coleman, C. M.; Twining, L. A. Tetrahedron 2005, 61, 11488-11500.
40. (c) Wipf, P.; Xiao, J. Org. Lett. 2005, 7, 103-106.
41. (d) Wipf, P.; Xiao, J.; Geib, S. J. Adv. Synth. Catal. 2005, 347, 1605-1613.
42. (a) Cheng, R. P.; Gellman, S. H.; Degrado, W. F. Chem. Rev. 2001, 101, 3219-3232.
43. (b) Seebach, D.; Beck, A. K.; Brenner, M.; Gaul, C.; Heckel, A. Chimia 2001, 55, 831-838.
44. (c) Lee, M.-R.; Raguse, T. L.; Schinnerl, M.; Pomerantz, W. C.; Wang, X.; Wipf, P.; Gellman, S. H. Org. Lett. 2007, 9, 1801-1804.
45. (a) Nelson, S. G.; Spencer, K. L. Angew. Chem., Int. Ed. 2000, 39, 1323-1325.
46. (b) Wang, X.; Nelson, S. G.; Curran, D. P. Tetrahedron 2007, 63, 6141-6145.
47. Generated in situ from fluorescein isothiocyanate and Frnoclysine.